“Clinically significant pharmacokinetic interactions between aprepitant/fosaprepitant and bosutinib PO, cabazitaxel IV, cyclophosphamide IV, dexamethasone PO, methylprednisolone …/IV, oxycodone PO and tolbutamide PO were identified, as were adverse events resulting from an interaction between aprepitant/fosaprepitant … alcohol , anthracyclines, ifosfamide, oxycodone, quetiapine, selective serotonin …/serotonin-norepinephrine reuptake inhibitors and warfarin.”